Company / Total Assets
Foghorn Therapeutics Inc. Total Assets History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$198.1M
FY2025
5-year range
$198.1M / $404.9M
FY2021-FY2025
Trend
-30.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has declined for 3 consecutive years, from $405M in FY2022 to $198M in FY2025.
Based on SEC 10-K filings.
$198M in FY2025 with a 5-year CAGR of -5.0%.
Declined from $286M to $198M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -21.2%
- 5-Year CAGR
- -5.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- Foghorn Therapeutics Inc.'s total assets has declined for 3 consecutive years.
- 5-year CAGR of -5.0%, indicating a declining trend.
- In FY2025, total assets decreased 30.2% year-over-year.
- Peak total assets was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -1.20 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $198.1M | -30.2% |
| FY2024 | $284.0M | -0.7% |
| FY2023 | $285.9M | -29.4% |
| FY2022 | $404.9M | +58.4% |
| FY2021 | $255.6M | +0.0% |
| FY2020 | $255.6M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026